| calcium channel, voltage-dependent, beta 2 subunit |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
1-(2-CHLOROBENZOYL)-4-(PHENYLMETHYL)-PIPERIDINE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| platelet-derived growth factor receptor, beta polypeptide |
1-NAPHTHYL ISOTHIOCYANATE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
| interleukin 8 receptor, beta |
1-NAPHTHYL ISOTHIOCYANATE |
Chemokine CXCR2 (IL-8B) |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, iota |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, beta 1 |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, delta |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, mu |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, theta |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, iota |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, epsilon |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, zeta |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, gamma |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, delta |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase D1 |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, theta |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, epsilon |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, gamma |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| protein kinase C, alpha |
MITOTANE |
Phorbol Ester |
-20% |
NoneNone |
NoneNone |
View
|
| platelet derived growth factor receptor, alpha polypeptide |
1-NAPHTHYL ISOTHIOCYANATE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
| platelet-derived growth factor receptor, alpha polypeptide |
1-NAPHTHYL ISOTHIOCYANATE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
| platelet derived growth factor receptor, beta polypeptide |
1-NAPHTHYL ISOTHIOCYANATE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
DIELDRIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
DIELDRIN |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, muscarinic 2 |
MITOTANE |
Muscarinic M2 |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
MITOTANE |
Serotonin 5-HT1A |
-20% |
NoneNone |
NoneNone |
View
|
| 5-hydroxytryptamine (serotonin) receptor 1A |
MITOXANTRONE |
Serotonin 5-HT1A |
-20% |
NoneNone |
NoneNone |
View
|
| DNA encoding receptor of vasoactive intestinal polypeptide |
MITOXANTRONE |
Vasoactive Intestinal Peptide VIP1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
MITOXANTRONE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
MITOXANTRONE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 1a |
DIELDRIN |
Adrenergic alpha1A |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
CARBAMAZEPINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
CARBAMAZEPINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| histamine receptor H 1 |
DIELDRIN |
Histamine H1, Central |
-20% |
NoneNone |
NoneNone |
View
|
| adenosine A1 receptor |
N,N'-DIPHENYL-P-PHENYLENEDIAMINE |
Adenosine A1 |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 1 |
LEAD (II) ACETATE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 7 |
LEAD (II) ACETATE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X-like 1, orphan receptor |
LEAD (II) ACETATE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| endothelin receptor type A |
N,N'-DIPHENYL-P-PHENYLENEDIAMINE |
Endothelin ETA |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
DIPHENHYDRAMINE |
Calcium Channel Type L, Dihydropyridine |
-20% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
SPECTINOMYCIN |
Insulin |
-20% |
NoneNone |
NoneNone |
View
|
| insulin receptor |
SPECTINOMYCIN |
Insulin |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 1 |
ASTEMIZOLE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 7 |
ASTEMIZOLE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X-like 1, orphan receptor |
ASTEMIZOLE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
ASTEMIZOLE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
ASTEMIZOLE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
ASTEMIZOLE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
ASTEMIZOLE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| cathepsin G |
NIMESULIDE |
Protease, Cathepsin G |
-20% |
NoneNone |
NoneNone |
View
|
| mast cell protease 9 |
NIMESULIDE |
Protease, Cathepsin G |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, kainate 1 |
CLOBETASOL PROPIONATE |
Glutamate, Kainate |
-20% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
NOSCAPINE |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
| v-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian) |
NOSCAPINE |
Protein Tyrosine Kinase, HER2 Receptor |
-20% |
NoneNone |
NoneNone |
View
|
| endothelin receptor type A |
NOSCAPINE |
Endothelin ETA |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, kainate 5 |
CLOBETASOL PROPIONATE |
Glutamate, Kainate |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, kainate 4 |
CLOBETASOL PROPIONATE |
Glutamate, Kainate |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, kainate 3 |
CLOBETASOL PROPIONATE |
Glutamate, Kainate |
-20% |
NoneNone |
NoneNone |
View
|
| glutamate receptor, ionotropic, kainate 2 |
CLOBETASOL PROPIONATE |
Glutamate, Kainate |
-20% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, dopamine), member 3 |
SPECTINOMYCIN |
Dopamine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
CLOMIPHENE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 1 |
CLOMIPHENE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 1 |
CLOMIPHENE |
Protein Serine/Threonine Kinase, ERK2 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
TIBOLONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
TIBOLONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| synaptic vesicle glycoprotein 2b |
CADMIUM ACETATE |
beta-Lactamase |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
CHLORTETRACYCLINE |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| leukotriene C4 synthase |
CHLORTETRACYCLINE |
Leukotriene C4 Synthetase |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 9 |
CLOMIPHENE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 10 |
CLOMIPHENE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, epsilon polypeptide |
CLOMIPHENE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, beta polypeptide 4 |
CLOMIPHENE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 5 |
CLOMIPHENE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, beta polypeptide 1 (muscle) |
CLOMIPHENE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
SPIRONOLACTONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
SPIRONOLACTONE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
CLOBETASOL PROPIONATE |
Adrenergic alpha2B |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
VENLAFAXINE |
Adrenergic alpha2B |
-20% |
NoneNone |
NoneNone |
View
|
| solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
AZASERINE |
Adrenergic, Norepinephrine Transporter |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 9 |
VENLAFAXINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, alpha polypeptide 10 |
VENLAFAXINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| cholinergic receptor, nicotinic, epsilon polypeptide |
VENLAFAXINE |
Nicotinic Acetylcholine, Central |
-20% |
NoneNone |
NoneNone |
View
|
| estrogen receptor 1 |
OXICONAZOLE |
Estrogen ERalpha |
-20% |
NoneNone |
NoneNone |
View
|
| estrogen receptor 1 |
OXICONAZOLE |
Estrogen ERalpha |
-20% |
NoneNone |
NoneNone |
View
|
| arginine vasopressin receptor 1A |
OXYTETRACYCLINE |
Vasopressin V1A |
-20% |
NoneNone |
NoneNone |
View
|
| adrenergic receptor, alpha 2b |
RIMANTADINE |
Adrenergic alpha2B |
-20% |
NoneNone |
NoneNone |
View
|
| estrogen receptor 1 |
OXYTETRACYCLINE |
Estrogen ERalpha |
-20% |
NoneNone |
NoneNone |
View
|
| estrogen receptor 1 |
OXYTETRACYCLINE |
Estrogen ERalpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
OXICONAZOLE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
OXICONAZOLE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3B |
OXYQUINOLINE |
Phosphodiesterase PDE3 |
-20% |
NoneNone |
NoneNone |
View
|
| phosphodiesterase 3A |
OXYQUINOLINE |
Phosphodiesterase PDE3 |
-20% |
NoneNone |
NoneNone |
View
|
| platelet derived growth factor receptor, alpha polypeptide |
TROXIPIDE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
| platelet-derived growth factor receptor, alpha polypeptide |
TROXIPIDE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
| platelet derived growth factor receptor, beta polypeptide |
TROXIPIDE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
| platelet-derived growth factor receptor, beta polypeptide |
TROXIPIDE |
Platelet-Derived Growth Factor (PDGF) |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 |
EBASTINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase) |
EBASTINE |
Cyclooxygenase COX-1 |
-20% |
NoneNone |
NoneNone |
View
|
| FMS-like tyrosine kinase 1 |
SULFAPHENAZOLE |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
| fms-related tyrosine kinase 1 (vascular endothelial growth factor/vascular permeability factor receptor) |
SULFAPHENAZOLE |
Vascular Endothelinal Growth Factor (VEGF) |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen activated protein kinase 14 |
RIMANTADINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| mitogen-activated protein kinase 14 |
RIMANTADINE |
Protein Serine/Threonine Kinase, p38alpha |
-20% |
NoneNone |
NoneNone |
View
|
| cholecystokinin A receptor |
EBASTINE |
Cholecystokinin CCKA |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, gamma |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, delta |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1, beta (Liddle syndrome) |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, nonvoltage-gated 1 alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type X, alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage gated, type VIII, alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type V, alpha (long QT syndrome 3) |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, beta |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type II, alpha 2 |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 1 |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 2 |
ALLOPURINOL |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
SODIUM ARSENITE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
SODIUM ARSENITE |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, beta |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 1 |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel associated protein 2 |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, alpha |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IX, alpha |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VII, alpha |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| amiloride-sensitive cation channel 5, intestinal |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type III, beta |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type VIII, alpha polypeptide |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type XI, alpha |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type I, beta |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type 10, alpha polypeptide |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| sodium channel, voltage-gated, type IV, alpha polypeptide |
NEVIRAPINE |
Sodium Channel, Site 2 |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
2-ACETYLAMINOFLUORENE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 3 |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 2 |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 1 |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 4 subunit |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 3 subunit |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 2 subunit |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1S subunit |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha 1F subunit |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1D subunit |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1C subunit |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, P/Q type, alpha 1A subunit |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, beta 1 subunit |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, L type, alpha 1E subunit |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, N type, alpha 1B subunit |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, alpha2/delta subunit 1 |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| matrix metalloproteinase 1 (interstitial collagenase) |
1-NAPHTHYL ISOTHIOCYANATE |
Protease, Matrix Metalloprotease-1 (MMP-1) |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 1 |
1-NAPHTHYL ISOTHIOCYANATE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X, ligand-gated ion channel, 7 |
1-NAPHTHYL ISOTHIOCYANATE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| purinergic receptor P2X-like 1, orphan receptor |
1-NAPHTHYL ISOTHIOCYANATE |
Purinergic P2X |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 8 |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 7 |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 6 |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 5 |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| calcium channel, voltage-dependent, gamma subunit 4 |
1-NAPHTHYL ISOTHIOCYANATE |
Calcium Channel Type L, Benzothiazepine |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 |
RWJ-68354 |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|
| prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) |
RWJ-68354 |
Cyclooxygenase COX-2 |
-20% |
NoneNone |
NoneNone |
View
|